ABSTRACT
INTRODUCTION
Gallstone disease is a multifactorial disorder where both environmental and genetic factors contribute towards susceptibility to disease. The pathophysiology of cholesterol gallstone formation is complex because a large number of genes regulate cholesterol homeostasis. A prerequisite for the development of cholesterol gallstone is lithogenic bile, which is often the result of enhanced cholesterol synthesis or a reduced bile acid pool size, or both. Any imbalance in cholesterol homeostasis may lead to cholesterol supersaturation in bile. Lipoproteins, which are transporting vehicles of cholesterol, play an important role in cholesterol homeostasis.
Apolipoprotein B (Apo B) is the main protein component of low-density-lipoprotein (LDL) and contains several domains (1) . The expression of apo B gene, present on chromosome 2, is subject to tissue specific regulation (2, 3) . The human APOB is 43 kb in length with 81 bp signal sequence. Numerous polymorphisms have been identified on this gene. APOB 3' variable number of tandem repeat (VNTR) is located at 72 bp downstream to second putative polyadenylation signal and exhibits a variable number of 11-16 bp repeat (average variation 15 bp) consisting of the adenine-(A) and thymine-(T) rich sequences (4) . Association between APOB 3' VNTR polymorphism and the level of plasma lipid or lipoprotein or coronary heart disease have been reported in several populations. Higher alleles of APOB 3'-hypervariable region (HVR), in particular 48-repeat allele, have been associated with an increased risk of coronary heart disease (5). This APOB 3' VNTR region has also been associated with other diseases i.e. Obesity and Hypertension (6,7).
The APOB XbaI polymorphism is the result of a single base alteration in the exon 26, which does not change the amino acid sequence of apo B. This polymorphism has been found to be associated with interindividual variability of lipid levels but the results are conflicting (8) . The association of XbaI polymorphism with coronary heart diseases, non-insulin dependent diabetes mellitus, and cholesterolosis has been shown to be associated with dyslipidemia (9, 10, 11) . This polymorphism of APOB has also been studied in gallstone patients. Han et al. (12) found X + allele to be significantly higher, but in the Finnish population this polymorphism was not found to be associated with the gallstone disease (11, 12) .
The APOB, insertion/deletion polymorphism arises due to an insertion or a deletion of 9 base pairs, which produces a difference of 3 amino acids in the signal peptide (13, 14) . In vitro expression studies have shown that the deletion variant mediates inefficient translocation of apo B protein into the endoplasmic reticulum relative to the insertion variant (15) . Variations in plasma lipid concentration have been found associated with this polymorphism (16) .
Till now there is no study about the association of gallstone disease with APOB 3' VNTR, signal peptide insertion/deletion and exon 26 XbaI polymorphisms in Indian population. Moreover, studies evaluating APOB XbaI polymorphism in other populations have reported inconsistent results, possibly because of the lack of adequate statistical power, selection bias, population diversity, or genetic admixture. Therefore, aim of the present study was to explore the association of APOB 3' VNTR, XbaI, and insertion/deletion polymorphisms with gallstone disease. Since the gallstone disease is a worldwide problem and causes social and economic burden on the society, studies on environmental and genetic factors are important to unravel etiopathogenesis of the disease. Present study is also an effort in that direction. ), beween patients and controls respectively were statistically insignificant. All subjects were from North India. The gallstone patients were recruited among inpatients undergoing cholecystectomy and outpatients attending the clinics of Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences. Initially 350 controls were recruited from the healthy staff members of institute and general population of the region and 322 age and sex matched subjects who were found to be negative for gallstone (by ultrasound), diabetes mellitus, coronary artery disease, obesity, and other chronic debilitating disease, were included in the study. All patients and controls were unrelated to each other. Study was approved by local ethical committee of the institute. After an informed consent, blood was taken in EDTA for analysis of DNA. The genomic DNA was extracted from peripheral blood leucocytes pellet using the standard salting out method (17) .
MATERIALS AND METHODS

Subjects
Genotyping :
For APOB 3' VNTR analysis genomic DNA was amplified using primer sequence described by Boerwinkle et al. (18) The PCR product was resolved on 10% polyacrylamide gel electrophoresis along with a 50 bp molecular weight marker (Bangalore Genei, India). The molecular weight of each band was determined using an AlphaImager 1220 v5.5 (AlphaImager TM 1220, Alpha Innotech Corporation, USA) software program where the unknown samples were compared with a 50 bp ladder. The alleles were designated according to their respective base pair size taking the core repeat sequence as 15 bp for APOB 3' VNTR.
APOB XbaI polymorphism analysis was done as described previously (12) . Allele was designated X + when restriction site for XbaI was present. Alternative allele was designated X -. For APOB insertion/deletion polymorphism, specific region was amplified using primers described by Boerwinkle et al (19) . For genotyping PCR products were run on 20% polyacrylamide gel.
Statistical Evaluation :
To examine whether the genotype frequencies were in Hardy-Weinberg equilibrium Goodness of fit χ 2 test was used. All other analyses were done using SPSS v11.5 in whole study population and, in male and female population separately. Genotype and allele frequencies were determined by direct counting and compared by χ 2 test or Fisher's exact test. Logistic regression analysis was used to find out contribution of genetic polymorphisms to the risk of disease. Models were constructed to obtain odds ratios for each allele after adjustment for the effect of age, sex, and body mass index (BMI).
RESULTS
Allele and Genotype Frequency APOB 3' VNTR polymorphism : In control population total 27 alleles, ranging from 30 repeat allele to 57 repeat allele, were observed. In patients total 33 alleles, ranging from 31 repeat allele to 66 repeat allele were observed. Longer alleles (more than 49 repeat allele) were more frequent in patients than in controls, alleles longer than 57 repeat were present only in patient group. The VNTR polymorphism was not in Hardy-Weinberg equilibrium (P=0.000) that might be due to presence of a large number of alleles in the studied population.
To make analysis uncomplicated, alleles were coded in three allele model. Up to 38 repeat were kept in short (S) allele group. In medium (M) allele group most common alleles (39-49 repeat) and in long (L) allele group, more than 49 repeats were included. This polymorphism was found to be significantly associated with gallstone disease (Table 1) . Longer allele group was imposing significantly high risk (P=1.52x10 -13 ; OR=3.705, 95% CI 2.577-5.326) for the disease, on the other hand medium allele group was protective (P=5.07x10 -10 ; OR=0.406, 95% CI 0.304-0.542) for the disease.
To nullify the effect of gender, data was further stratified into male and female population. APOB 3' VNTR, L alleles were imposing risk and M alleles were protective in both male and female population (Table 1) .
APOB XbaI polymorphism :
Studied control and patient population were in Hardy-Weinberg equilibrium (P=0.532 and P=0.151 respectively) for APOB XbaI polymorphism. In controls heterozygosity was 39.69% and homozygous X +/+ was present in 5%.
Frequency of APOB XbaI genotypes has been shown in Table  2 . Although frequency of X +/+ was lower (2.91% vs. 5.00%) in patients than in controls but difference was not statistically significant. When stratified gender wise, analysis in male showed slightly higher (57.81% vs. 53.91%) frequency of X -/-and slightly lower frequency of X +/-and X +/+ in patients than in controls. Distribution of X + and X -allele was also not different between patient and control groups (Table 3) . Separate analysis of male and female population did not reveal any statistically significant difference in frequency of alleles.
APOB insertion/ deletion polymorphism :
This polymorphism was in Hardy-Weinberg equilibrium in both patient (P=0.895) and control (P=0.461) study population. Table 2 shows the frequency of APOB insertion/deletion polymorphism, genotypes in patients and control group. In patients, frequency of II was higher (71.50% vs. 64.71%), conversely frequency of ID was lower (25.60% vs. 32.94%), than in controls but the differences were not statistically significant. Genotype DD showed almost similar frequency in both the groups.
Gender based stratification of the study population revealed that APOB insertion/deletion polymorphism was associated neither in the males nor in females, with gallstone disease (Table 2) . Trends for the distribution of genotypes in males and females were same as observed in total population.
Frequency of D allele was lower and frequency of I allele was higher in patients than in controls (Table 3) . Stratification of study population in male and female showed same trends of frequency distribution in patients and controls but no difference was statistically significant.
Risk Assessment :
To determine the contribution of different alleles to the risk of gallstone disease logistic regression analysis was used. Results of logistic regression analysis are given in Table 4 . APOB VNTR, L alleles were imposing significantly high risk for the gallstone disease. A significant number (6.8%) of gallstone cases could be predicted by L # S allele= lowest-38 repeat; M allele= 39-49 repeat; L allele= 50-above repeat; *Total number of chromosome alleles alone, addition of age, sex and BMI in the models led to high increase in R 2 (7.2%); on the other hand, X -allele could explain very few cases (0.7%). APOB insertion/deletion polymorphism was also not found to contribute significantly to the risk for gallstone disease even after the adjustment.
DISCUSSION
Gallstone disease is a major problem in India and with privileged circumstances and urbanization in rural villages; its rate may increase in future Alterations in lipids have been associated with disease but the mechanism is unknown. Apo B is essential for the synthesis and secretion of both chylomicrons and VLDL (20) . Plasma lipoprotein change induced by dietary fat and cholesterol has been correlated to certain APOB genetic polymorphisms. Therefore, in present study we analyzed association of three polymorphisms present on APOB i.e. 3' untranslated region VNTR, exon 26 XbaI, and signal peptide insertion/ deletion, with gallstone disease. Table 3 : APOB XbaI and insertion/deletion polymorphism allele frequency in total subjects and stratified in male and female subjects This is the first study reporting the association between the APOB 3' VNTR and gallstone disease. Longer alleles (more than 49) were found to have considerable risk for the development of disease; on the other hand medium allele were protective for the disease in male and female both (Table 1) . Regression models revealed L alleles to be strongly associated with the disease and predicted a significant proportion of gallstone disease (Table 4) . In other diseases also where lipoprotein metabolism is abnormal, like coronary artery disease and diabetes mellitus, APOB VNTR alleles with higher repeat number have been reported to occur more frequently in patients than in controls (21, 22, 23) . Medium alleles are wild type and most likely represent alleles associated with normal expression levels of APOB gene and protection for the disease.
Since these repeats are present in 3' untranslated region, they do not play any role in structure of apo B protein. APOB 3' VNTR may have some role in gene expression or may be in linkage disequilibrium with other polymorphism either in the same gene or in other nearby genes, whose function is still not known (24, 25) . Higher repeat alleles or other alleles with which these alleles are in linkage disequilibrium may have some effect on regulation of gene expression, which ultimately results in abnormal cholesterol transport, supersaturation of bile with cholesterol and development of gallstones. Here we suggest that APOB 3'VNTR polymorphism is certainly related to the disease but pathway may not be direct.
Other studied polymorphisms i. e. APOB XbaI and insertion/ deletion, were not found to be associated with gallstone disease in present study. APOB XbaI, which is due to a single base variation in exon 26 of the APOB that does not lead to changes in the amino acid sequence. Studies about this APOB XbaI polymorphism and gallstone disease have indicated contradictory results. APOB XbaI polymorphism in Chinese gallstone patients showed that frequencies of X +/-and X -/-were significantly different between the patients and controls and the frequency of X + allele in the patients was significantly higher than that in the controls (0.104 vs. 0.052) (26) . Another study in the same Chinese population also showed that frequency of the rare allele X + and the distribution of X +/-genotype were significantly higher in the patient group than controls (27) . We did not find any association of APOB XbaI polymorphism with gallstone disease but frequency of X -/-was slightly higher and frequency of X +/+ was slightly lower in patients than controls ( Table 2, 3 ). Trends in our study support the Finish study, in which Juvonen et al (11) found that distribution of XbaI genotypes in the gallstone patients did not differ significantly from that of controls.
It appears that APOB XbaI polymorphism exhibits population specific variation, which may be due to gene and environment interactions. In previous studies number of gallstone patients was also small, which might have influenced the results. APOB XbaI polymorphism does not lead to changes in the amino acid sequence and can not be implicated at structure level. It is possible that some other polymorphism in its vicinity might be present in Chinese population, which is in linkage disequilibrium with APOB XbaI polymorphism and showing association with gallstone disease.
APOB insertion-deletion polymorphism alters the N-terminal signal sequence and may alter the apo B secretion and lipoprotein levels (28, 29) . Studies have reported that deletion allele carriers may be less responsive to an increased amount of dietary fat (28, 30) . This is the first study analyzing this association in gallstone disease. In present study gallstone disease was not found to be influenced by this polymorphism. This polymorphism may not be involved in causation of gallstone disease, more studies in different population is needed to confirm the results. In a meta-analysis, this polymorphism was not associated with plasma total, LDL-, or HDL-cholesterol levels (31), which support no role of this polymorphism in dyslipidemia.
Since this is the first study of its kind, more studies in different populations are needed to confirm it. Establishment of highrisk alleles for gallstone development will certainly help in recognition of individuals at high risk and management of disease. Determination of genetic factors will allow lifestyle changes to lower the risk and more intensive medical surveillance to detect the asymptomatic gallstones. Early diagnosis is always very useful to prevent complication associated with gallstone disease, including gallbladder cancer. We conclude that longer alleles of APOB 3' VNTR occur more frequently in gallstone patients, and may be an important risk factor for the development of disease. APOB XbaI and signal peptide insertion/deletion polymorphism may not be contributing to the risk for gallstone disease.
